Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 241–255 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5584 PRRT2 Gene (Benign Familial Infantile Seizures Type 2) Genetic Test This genetic test identifies pathogenic variants in the PRRT2 gene associated with benign familial infantile seizures type 2 (BFIS2).	Whole blood (EDTA tube), dried blood spot (FTA card), or pre-extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRRT2 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Diagnosis of benign familial infantile seizures type 2 (BFIS2)", "Evaluation of infants with early-onset epilepsy"] Measurement technique Confirm with laboratory Codes LOINC: 92238-4 ICD-10: G40.89, Z82.0, Z13.85 Clinical summary This genetic test identifies pathogenic variants in the PRRT2 gene associated with benign familial infantile seizures type 2 (BFIS2).
TEST-4990 PSAP Gene Sequencing for Metachromatic Leukodystrophy (Saposin B Deficiency) Test This test analyzes the PSAP gene for pathogenic variants associated with Metachromatic Leukodystrophy (Saposin B Deficiency). It uses Next-Generation Sequencing (NGS) to detect mut...	Peripheral whole blood, dried blood spot, or extracted DNA	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PSAP gene", "Point mutations", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Clinical suspicion of Metachromatic Leukodystrophy (MLD)", "Family history of MLD", "Carrier screening", "Prenatal diagnosis", "Preimplantation genetic diagnosis (PGD)"] Measurement technique Confirm with laboratory Codes LOINC: 94450-8 ICD-10: E75.25 Clinical summary This test analyzes the PSAP gene for pathogenic variants associated with Metachromatic Leukodystrophy (Saposin B Deficiency). It uses Next-Generation Sequencing (NGS) to detect mutations, including point mutations, indels, and copy number variants.
TEST-5901 PTF1A Gene Pancreatic Agenesis Type 2 Genetic Test This genetic test analyzes the PTF1A gene to detect mutations causing pancreatic agenesis type 2.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PTF1A gene sequence", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No fasting required", "No medication adjustments required unless advised by physician"] Indications ["Suspected pancreatic agenesis type 2", "Neonatal diabetes mellitus", "Family history of pancreatic agenesis"] Measurement technique Confirm with laboratory Codes LOINC: 94471-7 ICD-10: Q45.0 Clinical summary This genetic test analyzes the PTF1A gene to detect mutations causing pancreatic agenesis type 2.
TEST-5333 PTPN14 Gene Choanal Atresia and Lymphedema Genetic Test This genetic test identifies pathogenic variants in the PTPN14 gene, confirming hereditary lymphedema-choanal atresia syndrome.	Peripheral whole blood, extracted DNA, or FTA card (dried blood spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PTPN14 gene", "Coding and splice-site variants"] Parameters [] Preparation ["No fasting or special preparation needed", "Prior genetic counseling is strongly recommended"] Indications ["Diagnosis of hereditary lymphedema-choanal atresia syndrome", "Assessment of cancer predisposition associated with PTPN14 variants"] Measurement technique Confirm with laboratory Codes LOINC: 91853-6 ICD-10: Q87.8, Q30.0, I89.0 Clinical summary This genetic test identifies pathogenic variants in the PTPN14 gene, confirming hereditary lymphedema-choanal atresia syndrome.
TEST-5233 PYCR1 Gene (Cutis Laxa Type 3B, Autosomal Recessive) Genetic Test This genetic test identifies pathogenic variants in the PYCR1 gene associated with autosomal recessive cutis laxa type 3B.	Whole Blood or FTA Card Specimen	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PYCR1 gene", "Point mutations", "Small indels", "CNVs (deletions/duplications)"] Parameters [] Preparation ["Clinical history form required", "Genetic counseling session required", "Parental consent required for minors"] Indications ["Suspected diagnosis of autosomal recessive cutis laxa type 3B", "Family history of cutis laxa", "Genetic counseling for hereditary skin disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94448-5 ICD-10: Q82.8, Z15.09, L98.8 Clinical summary This genetic test identifies pathogenic variants in the PYCR1 gene associated with autosomal recessive cutis laxa type 3B.
TEST-2616 RAB3GAP2 Gene (Martsolf Syndrome) Genetic Test This test analyzes the RAB3GAP2 gene to detect pathogenic variants associated with Martsolf syndrome.	Whole Blood (EDTA) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RAB3GAP2 gene coding region", "RAB3GAP2 gene splice sites"] Parameters [] Preparation ["No fasting required", "No medication adjustments needed unless advised by physician"] Indications ["Suspected Martsolf syndrome", "Patients presenting with the classic triad of congenital cataracts, developmental delay, and hypogonadism"] Measurement technique Confirm with laboratory Codes LOINC: 81315-1 ICD-10: Q87.8 Clinical summary This test analyzes the RAB3GAP2 gene to detect pathogenic variants associated with Martsolf syndrome.
TEST-2491 RAF1 Gene Noonan Syndrome Type 5 Genetic Test This test identifies pathogenic variants in the RAF1 gene, confirming a diagnosis of Noonan Syndrome Type 5.	Whole Blood (EDTA), Buccal Swab, or Extracted Genomic DNA	14 – 21 Working Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RAF1 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Individuals presenting with clinical features consistent with a RASopathy", "Confirmatory testing in patients with a known familial RAF1 mutation", "Differential diagnosis of Noonan Syndrome subtypes"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the RAF1 gene, confirming a diagnosis of Noonan Syndrome Type 5.
TEST-5575 RBCK1 Gene Polyglucosan Body Myopathy Type 1 (PGBM1) Test This test identifies pathogenic mutations in the RBCK1 gene, confirming a diagnosis of Polyglucosan Body Myopathy Type 1 (PGBM1).	Whole blood, Extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RBCK1 gene"] Parameters [] Preparation [] Indications ["Clinical symptoms suggesting RBCK1-related myopathy", "Family history suggestive of RBCK1-related myopathy", "Preliminary investigations suggesting RBCK1-related myopathy"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.0 Clinical summary This test identifies pathogenic mutations in the RBCK1 gene, confirming a diagnosis of Polyglucosan Body Myopathy Type 1 (PGBM1).
TEST-5812 REEP2 (SPG72) Gene Genetic Test This test identifies pathogenic variants in the REEP2 gene associated with Hereditary Spastic Paraplegia Type 72.	Whole blood (EDTA), Extracted DNA (≥1 µg), or Dried Blood Spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the REEP2 gene"] Parameters [] Preparation [] Indications ["Diagnosis of Hereditary Spastic Paraplegia Type 72", "Family at-risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the REEP2 gene associated with Hereditary Spastic Paraplegia Type 72.
TEST-6020 RFX6 Gene Mitchell‑Riley Syndrome Genetic Test This genetic test analyzes the RFX6 gene to detect mutations associated with Mitchell‑Riley syndrome.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RFX6 gene sequence", "Single-nucleotide variants (SNVs)", "Insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required for blood draw", "Do not discontinue prescribed medication without consulting physician"] Indications ["Confirmatory diagnosis in neonates with clinical suspicion", "Family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 95005-5 ICD-10: Q87.8 Clinical summary This genetic test analyzes the RFX6 gene to detect mutations associated with Mitchell‑Riley syndrome.
TEST-3518 RGS9 Gene Bradyopsia Genetic Test This genetic test identifies pathogenic variants in the RGS9 gene associated with bradyopsia, a rare inherited retinal disorder affecting light adaptation.	Peripheral whole blood or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RGS9 gene", "Molecular diagnosis of bradyopsia"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory"] Indications ["Suspected bradyopsia based on clinical symptoms", "Family history of RGS9 mutations", "Carrier screening in families with known RGS9 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: H53.72 Clinical summary This genetic test identifies pathogenic variants in the RGS9 gene associated with bradyopsia, a rare inherited retinal disorder affecting light adaptation.
TEST-2500 RIT1 Gene Noonan Syndrome Type 8 Genetic Test This test detects pathogenic single-nucleotide variants and small insertions or deletions within the coding exons and flanking intronic regions of the RIT1 gene.	Whole Blood (EDTA) or FTA Card	21–28 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic single-nucleotide variants in RIT1 gene", "Small insertions or deletions in RIT1 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of Noonan Syndrome Type 8", "Family history of Noonan Syndrome Type 8", "Need for precise clinical management and family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 81321-6 ICD-10: Q87.1 Clinical summary This test detects pathogenic single-nucleotide variants and small insertions or deletions within the coding exons and flanking intronic regions of the RIT1 gene.
TEST-6227 RMND1 Gene Combined Oxidative Phosphorylation Deficiency Type 11 Genetic Test This genetic test identifies disease-causing mutations in the RMND1 gene, confirming a diagnosis of combined oxidative phosphorylation deficiency type 11.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3-4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RMND1 gene sequence", "Pathogenic variants in RMND1"] Parameters [] Preparation ["No fasting required", "Avoid strenuous physical exertion for 24 hours before sample collection", "Inform phlebotomist of recent blood transfusions", "Continue all prescribed medications unless directed otherwise by physician"] Indications ["Unexplained mitochondrial encephalopathy", "Hypotonia", "Developmental delay", "Elevated lactate"] Measurement technique Confirm with laboratory Codes LOINC: 21659-2 ICD-10: E74.81 Clinical summary This genetic test identifies disease-causing mutations in the RMND1 gene, confirming a diagnosis of combined oxidative phosphorylation deficiency type 11.
TEST-5014 RPL21 Gene Hypotrichosis Type 12 Genetic Test This genetic test identifies pathogenic variants in the RPL21 gene associated with hypotrichosis type 12.	Whole blood (EDTA, 3-5 mL) or FTA card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RPL21 gene", "Single-nucleotide resolution across coding exons"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Diagnosis of hypotrichosis type 12", "Genetic counselling for families with affected individuals", "Informed family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q84.0 Clinical summary This genetic test identifies pathogenic variants in the RPL21 gene associated with hypotrichosis type 12.
TEST-3282 RPS17 Gene Diamond-Blackfan Anemia Type 4 Genetic Test This genetic test detects pathogenic variants in the RPS17 gene, which are linked to Diamond-Blackfan anemia type 4.	Peripheral whole blood or buccal swab	3–4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RPS17 gene", "Single-nucleotide variants", "Copy-number variations"] Parameters [] Preparation ["No fasting required"] Indications ["Diagnostic confirmation of Diamond-Blackfan anemia type 4", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21674-6 ICD-10: D61.09 Clinical summary This genetic test detects pathogenic variants in the RPS17 gene, which are linked to Diamond-Blackfan anemia type 4.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.